pfizer glp-1 pipeline ADA '26: Lilly's dominance, Pfizer's 'foundational' drug and Roche's 'me-too' option Pfizer boosts weight loss pipeline

Moreover, the DPP-4-generated metabolites of GLP-1 (Figure 1), lacking the His-Ala dipeptide, have 100-fold less affinity towards GLP-1R

Pharmaceutical companies refined the approach, developing longer-acting versions based on modified human GLP-1

Exercise, especially strength training, a healthy diet, stress reduction, adequate sleep and weight management, particularly for those who are overweight, are just a few

Responding to complaints about high costs, Eli Lilly, maker of Zepbound, says in part: "Obesity is a chronic, progressive disease, and people with obesity deserve for it to be treated like one." Doctors say insurance will still cover the drugs for things like diabetes